|
GlaxoSmithKline Pharmaceuticals Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
52624.29 Cr.
|
P/BV
|
21.01
|
Book Value (Rs.)
|
147.85
|
|
52 Week High/Low (Rs.)
|
3121/2088
|
FV/ML
|
10/1
|
P/E(X)
|
50.80
|
|
Bookclosure
|
29/05/2026
|
EPS (Rs.)
|
61.15
|
Div Yield (%)
|
1.83
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 3807.55 | 3726.03 | 3441.77 | 3226.38 | 3264.08 |
| Other Operating Revenues | 14.12 | 23.18 | 11.94 | 25.34 | 13.95 |
| Total Operating Revenues | 3821.67 | 3749.21 | 3453.71 | 3251.72 | 3278.03 |
| | | | | | |
| Other Income | 145.36 | 145.93 | 122.59 | 100.66 | 75.78 |
| Total Revenue | 3967.03 | 3895.14 | 3576.30 | 3352.38 | 3353.80 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 436.15 | 499.90 | 545.17 | 427.49 | 611.18 |
| Purchase Of Stock-In Trade | 910.44 | 845.11 | 853.08 | 788.43 | 729.44 |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 73.85 | 0.00 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 4.46 | 45.85 | -63.72 | 68.96 | 15.57 |
| Employee Benefit Expenses | 607.25 | 579.70 | 624.39 | 594.99 | 610.23 |
| Finance Costs | 2.73 | 1.31 | 1.80 | 1.81 | 2.00 |
| Depreciation And Amortisation Expenses | 66.44 | 66.79 | 69.68 | 65.77 | 68.19 |
| Other Expenses | 554.17 | 601.29 | 586.10 | 493.73 | 549.73 |
| Total Expenses | 2581.65 | 2639.95 | 2616.50 | 2515.02 | 2586.33 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1385.39 | 1255.19 | 959.80 | 837.37 | 767.47 |
| | | | | | |
| Exceptional Items | 20.63 | 4.69 | -143.62 | -0.97 | 11.58 |
| Profit/Loss Before Tax | 1406.01 | 1259.88 | 816.19 | 836.40 | 779.05 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 360.57 | 325.96 | 237.59 | 247.13 | 219.74 |
| Deferred Tax | 9.46 | 6.34 | -11.36 | -18.37 | -9.40 |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 187.94 |
| Total Tax Expenses | 370.03 | 332.30 | 226.23 | 228.76 | 398.28 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 1035.98 | 927.58 | 589.96 | 607.64 | 380.77 |
| | | | | | |
| Profit/Loss From Continuing Operations | 1035.98 | 927.58 | 589.96 | 607.64 | 380.77 |
| | | | | | |
| Profit/Loss From Discontinuing Operations | 0.00 | 0.00 | 0.00 | 4.13 | 1708.18 |
| Total Tax Expenses Discontinuing Operations | 0.00 | 0.00 | 0.00 | 1.08 | 394.23 |
| Net Profit/Loss From Discontinuing Operations | 0.00 | 0.00 | 0.00 | 3.04 | 1313.95 |
| Profit/Loss For The Period | 1035.98 | 927.58 | 589.96 | 610.69 | 1694.72 |
| | | | | | |
| Minority Interest | 0.00 | 2.66 | 4.17 | 6.04 | 0.00 |
| Consolidated Profit/Loss After MI And Associates | 1035.98 | 930.24 | 594.13 | 616.72 | 1694.72 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 61.15 | 54.52 | 41.14 | 36.08 | 99.29 |
| Diluted EPS (Rs.) | 61.15 | 54.76 | 34.83 | 36.05 | 100.04 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 711.51 | 745.39 | 542.10 | 1524.66 | 508.22 |
